Dudediligence.

Vera Therapeutics, Inc

VERANASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$9,517,199

14 notices · 246,165 sh

Oct 2025 to Oct 2026

Reported ·

$5,695,715

19 sales · 1 buy · $249,985 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

10 of 19 reported sales carry the 10b5-1 box. Together they are 0.20% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-02: MARSHALL FORDYCE, Form 1442026-06-23: MARSHALL FORDYCE, Form 1442026-05-12: MARSHALL FORDYCE, Form 1442026-04-14: MARSHALL FORDYCE, Form 1442026-02-23: LAURENCE SKELTON, Form 1442026-02-23: WILLIAM DONALD TURNER, Form 1442026-02-23: SEAN GRANT, Form 1442026-02-23: ROBERT BRENNER, Form 1442026-02-23: DAVID L JOHNSON, Form 1442026-02-23: MARSHALL FORDYCE, Form 1442025-12-15: WILLIAM TURNER, Form 1442025-12-08: WILLIAM TURNER, Form 1442025-12-03: WILLIAM TURNER, Form 1442025-11-21: Carter Jason S, Form 1442025-11-11: Young Joseph R, sold2025-11-21: Carter Jason S, sold2025-12-03: Turner William D., sold2025-12-08: Turner William D., sold2025-12-11: ENRIGHT PATRICK G, bought2025-12-15: Turner William D., sold2026-02-23: JOHNSON DAVID LEE, sold2026-02-23: Turner William D., sold2026-02-23: Fordyce Marshall, sold2026-02-23: Young Joseph R, sold2026-02-23: Grant Sean, sold2026-02-23: Brenner Robert, sold2026-02-23: Skelton Laurence Matthew, sold2026-04-14: Fordyce Marshall, sold2026-05-12: Fordyce Marshall, sold2026-06-23: Fordyce Marshall, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-02MARSHALL FORDYCE, PRESIDENT AND CEO$2,216,393
64,750 shplan 2026-01-09Form 4s on file end Jun 23144 ↗
2026-06-23MARSHALL FORDYCE, PRESIDENT AND CEO$2,843,820
74,000 shplan 2026-01-09Form 4s on file end Jun 23144 ↗
2026-05-12MARSHALL FORDYCE, PRESIDENT AND CEO$677,285
18,500 shplan 2026-01-09144 ↗
Form 4, 2026-05-13: sold 18,500 at $36.74 Form 4 ↗
2026-04-14MARSHALL FORDYCE, PRESIDENT AND CEO$1,003,188
22,951 shplan 2026-01-09144 ↗
Form 4, 2026-04-15: sold 22,951 at $44.05 Form 4 ↗
2026-02-23LAURENCE SKELTON, Chief Commercial Officer$75,663
1,800 shno plan date144 ↗
Form 4, 2026-02-25: sold 1,582 at $41.98 Form 4 ↗
2026-02-23WILLIAM DONALD TURNER, Chief Regulatory Officer$109,291
2,600 shplan 2025-12-23144 ↗
Form 4, 2026-02-25: sold 2,187 at $41.98 Form 4 ↗
2026-02-23SEAN GRANT, CHIEF FINANCIAL OFFICER$239,600
5,700 shplan 2026-01-09144 ↗
Form 4, 2026-02-25: sold 4,949 at $41.98 Form 4 ↗
2026-02-23ROBERT BRENNER, Chief Medical Officer$105,088
2,500 shplan 2026-01-09144 ↗
Form 4, 2026-02-25: sold 2,151 at $41.98 Form 4 ↗
2026-02-23DAVID L JOHNSON, Chief Operating Officer$121,902
2,900 shno plan date144 ↗
Form 4, 2026-02-25: sold 2,579 at $41.98 Form 4 ↗
2026-02-23MARSHALL FORDYCE, PRESIDENT AND CEO$697,781
16,600 shplan 2026-01-09144 ↗
Form 4, 2026-02-25: sold 16,925 at $41.98 Form 4 ↗
2025-12-15WILLIAM TURNER, Chief Regulatory Officer$498,000
10,000 shplan 2025-02-20144 ↗
Form 4, 2025-12-17: sold 10,000 at $50.08 Form 4 ↗
2025-12-08WILLIAM TURNER, Chief Regulatory Officer$449,000
10,000 shplan 2025-02-20144 ↗
Form 4, 2025-12-10: sold 10,000 at $45.31 Form 4 ↗
2025-12-03WILLIAM TURNER, Chief Regulatory Officer$372,500
10,000 shplan 2025-02-20144 ↗
Form 4, 2025-12-04: sold 10,000 at $40.00 Form 4 ↗
2025-11-21Carter Jason S, Chief Legal Officer$107,690
3,864 shno plan date144 ↗
Form 4, 2025-11-25: sold 3,864 at $27.82 Form 4 ↗